Article
Arsenic-Based Antineoplastic Drugs and Their Mechanisms of Action
9 Apr 2008
Abstract excerpt
Arsenic-based compounds have become accepted agents for cancer therapy providing high rates of remission of some cancers such as acute promyelocytic leukemia (APL). The mechanisms by which arsenic-containing compounds kill cells and reasons for selective killing of only certain types of cancer cells such as APLs have recently been delineated. This knowledge was gained in parallel with increasing understanding and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
